<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Borges S</submitter><funding>Health Sciences Teaching and Research Foundation’s</funding><funding>Research Support Foundation</funding><funding>Health Sciences Teaching and Research Foundation's</funding><pagination>23262</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11456598</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>This study aimed to evaluate the association between the questionnaires SARC-F and SARC-CalF with risk of mortality in patients undergoing hemodialysis (HD). A cohort study, with patients on HD age ≥ 18 years, both sex, between June 2019 and April 2023. Body composition (anthropometry and bioelectrical impedance), muscle functional (handgrip strength and gait speed), screening of sarcopenia using the SARC-F and SARC-CalF, nutritional status and laboratory data were assessed. Follow-up for mortality up to 47 months. The sample consisted of 243 participants and the prevalence of risk of sarcopenia using SARC-F and SARC-CalF were 30% and 45%, respectively; 65 died for all reasons and three patients were censored due to transplantation. Multivariate analysis identified SARC-CalF as predictor o</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Performance of SARC-F and SARC-CalF scores to predict risk of mortality in hemodialysis patients: a cohort study.</pubmed_title><pmcid>PMC11456598</pmcid><funding_grant_id>grant numbers 03, 2023</funding_grant_id><funding_grant_id>grant numbers 06, 2020</funding_grant_id><pubmed_authors>Ferreira Martins T</pubmed_authors><pubmed_authors>Cipriano G</pubmed_authors><pubmed_authors>Borges S</pubmed_authors><pubmed_authors>Lopes Alves M</pubmed_authors><pubmed_authors>Fortes RC</pubmed_authors><pubmed_authors>Franca Bernardelli Cipriano G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Performance of SARC-F and SARC-CalF scores to predict risk of mortality in hemodialysis patients: a cohort study.</name><description>This study aimed to evaluate the association between the questionnaires SARC-F and SARC-CalF with risk of mortality in patients undergoing hemodialysis (HD). A cohort study, with patients on HD age ≥ 18 years, both sex, between June 2019 and April 2023. Body composition (anthropometry and bioelectrical impedance), muscle functional (handgrip strength and gait speed), screening of sarcopenia using the SARC-F and SARC-CalF, nutritional status and laboratory data were assessed. Follow-up for mortality up to 47 months. The sample consisted of 243 participants and the prevalence of risk of sarcopenia using SARC-F and SARC-CalF were 30% and 45%, respectively; 65 died for all reasons and three patients were censored due to transplantation. Multivariate analysis identified SARC-CalF as predictor o</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-07T07:39:18.103Z</modification><creation>2025-04-04T01:54:35.292Z</creation></dates><accession>S-EPMC11456598</accession><cross_references><pubmed>39370431</pubmed><doi>10.1038/s41598-024-74412-6</doi></cross_references></HashMap>